Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated…

Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
Emilien Billon, Cécile Dalban, Stephane Oudard +17
European Urology Oncology9 Sep 2026Peer-reviewedLicence not stated6 citedGeneral biologyHAL
Association of BTRC rs10883617 with Survival Outcomes in Surgically Resected Non-Small Cell Lung Cancer
Seongwon Shin, Chi Young Jung, Mi Jeong Hong +14
Genes22 Sep 2026Peer-reviewedCC BYFull textGenetics & genomicsEurope PMC
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
Emeline Guiard, Florian Clatot, Caroline Even +5
European Journal of Cancer15 Sep 2026Peer-reviewedPublisher termsFull text20 citedGeneral biology OncologyHAL
473 Effect of nivolumab with or without relatlimab after stereotactic body radiotherapy in patients with advanced esophagogastric cancer
Chen Hu, Valsamo Anagnostou, Gavin Pereira +11
Journal for ImmunoTherapy of Cancer5 Nov 2026Peer-reviewedCC BYImmunology OncologyDOAJ
Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database
Laure Corazzin, Elodie Jeanbert, Olivier Glehen +26
Therapeutic Advances in Medical Oncology15 Jul 2026Peer-reviewedCC BY 4.0Full textGeneral biology Surgery & anaesthesiaHAL

Cite

BibTeX

@article{dalle2026updated,
  title = {{Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France}},
  author = {S. Dalle and P. Saiag and C. Lebbé and J.-J. Grob and Brigitte Dréno and S. Dalac and B. Asselain and F. Skowron and S. Darras and N. Jovenin and G. Quereux and A. Khammari and C. Rieuf and F. Brellier and S. Houssou and L. Mortier},
  journal = {European journal of cancer skin cancer},
  year = {2026},
  month = sep,
  doi = {10.1016/j.ejcskn.2024.100169},
  url = {https://hal.science/hal-05741858v1},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
AU  - S. Dalle
AU  - P. Saiag
AU  - C. Lebbé
AU  - J.-J. Grob
AU  - Brigitte Dréno
AU  - S. Dalac
AU  - B. Asselain
AU  - F. Skowron
AU  - S. Darras
AU  - N. Jovenin
AU  - G. Quereux
AU  - A. Khammari
AU  - C. Rieuf
AU  - F. Brellier
AU  - S. Houssou
AU  - L. Mortier
PY  - 2026
DA  - 2026/09/08
JO  - European journal of cancer skin cancer
DO  - 10.1016/j.ejcskn.2024.100169
UR  - https://hal.science/hal-05741858v1
SN  - 2772-6118
ER  -

Related

Cite